Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant human testicular, ovarian, and gastric carcinoma cell lines-Reference-Cited by-同舟云学术

Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant human testicular, ovarian, and gastric carcinoma cell lines

Published:1993 Issue:1 Volume:33 Page:43-47
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother. Pharmacol.

Author:

Harstrick Andreas,Bokemeyer Carsten,Scharnofkse Martin,Hapke Gunnar,Reile Dagmar,Schmoll Hans-Joachim

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF00686021.pdf

Reference17 articles.

1. Alberts DS, Mason L (1989) Carboplatin in the treatment of ovarian cancer. Semin Oncol 16 [Suppl 5]: 19?26

2. Asta Medica (1990) Clinical brochure for investigators: D-19 644. Asta Medica GmbH, Frankfurt

3. Bajorin DF, Sarosdy MF, Bosl GJ, Pfister DG, Mazumdar M, Motzer RJ, Scher HI, Geller NL, Fair WR, Herr H, Sogani P, Sheinfeld J, Russo P, Vlamis V, Carey R, Vogelzang NJ, Crawford ED, Bosl GJ (1993) A randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good risk germ cell tumors. J Clin Oncol 11: 598?606

4. Bunn PA (1989) Review of therapeutic trials of carboplatin in lung cancer. Semin Oncol 16 [Suppl 5]: 27?33

5. Fiebig H, Berger DP, Mross K, Queisser W, Aulenbacher P, Hilgard P (1992) Lobaplatin (D-19 466): preclinical drug profile and results of the phase I study. Ann Oncol 3 [Suppl]: 143

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Basics of Coordination Chemistry to Understanding Cisplatin-analogue Pt Drugs;Current Pharmaceutical Design;2023-06

2. Preliminary security investigation and short-time follow-up of intraoperative intraperitoneal chemotherapy with lobaplatin for advanced colorectal cancer;Oncology and Translational Medicine;2023-04

3. Lobaplatin-based neoadjuvant chemotherapy for triple-negative breast cancer: a 5-year follow-up of a randomized, open-label, phase II trial;Therapeutic Advances in Medical Oncology;2022-01

4. Comparison of the short‐term efficacy and serum markers between lobaplatin/paclitaxel‐ And carboplatin/paclitaxel‐based adjuvant chemotherapy in patient with ovarian cancer;Journal of Clinical Pharmacy and Therapeutics;2020-10-24

5. The role of hyperthermic intraperitoneal chemotherapy in the treatment of spontaneously ruptured hepatocellular carcinoma: a pilot study;Annals of Translational Medicine;2020-09